Evidence map›Paper›PMID 35545022›Full record

ArticleStem cell reports2022

SARS-CoV-2 and type I interferon signaling in brain endothelial cells: Blurring the lines between friend or foe.

George D Vavougios, Sotirios G Zarogiannis, Georgios Hadjigeorgiou, Karen A Krogfelt, Konstantinos I Gourgoulianis

Open access · goldAbstract readLetterComment
PubMed Full text at PMC Publisher
In one paragraph

Article in Stem cell reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.5field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 4 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

George D VavougiosDepartment of Neurology, Faculty of Medicine, University of Cyprus, 75 Kallipoleos Street, 1678, Lefkosia, Cyprus; Department of Respiratory Medicine, Faculty of Medicine, University of Thessaly, Biopolis, 41500, Larissa, Greece. Electronic address: gvavougyios@uth.gr.
Sotirios G ZarogiannisDepartment of Physiology, Faculty of Medicine, School of Health Sciences, University of Thessaly, Biopolis, 41500, Larissa, Greece.
Georgios HadjigeorgiouDepartment of Neurology, Faculty of Medicine, University of Cyprus, 75 Kallipoleos Street, 1678, Lefkosia, Cyprus.
Karen A KrogfeltDepartment of Molecular and Medical Biology, Centre for Mathematical Modeling - Human Health and Disease, PandemiX Center, Universitetsvej 1, 28A.1, 4000 Roskilde, Denmark.
Konstantinos I GourgoulianisDepartment of Respiratory Medicine, Faculty of Medicine, University of Thessaly, Biopolis, 41500, Larissa, Greece.
University of Cyprus · CYUniversity of Thessaly · GR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

COVID-19Interferon Type IBrainEndothelial CellsHumansSARS-CoV-2Interferon Type I

Identifiers

PMID35545022
PMCPMC9087889
OpenAlexW4280573769

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.